SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases

SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases

10.1128/mSystems.00614-20

Saved in:

Bibliographic Details
Main Authors:	Wu, F., Zhang, J., Xiao, A., Gu, X., Lee, W.L., Armas, F., Kauffman, K., Hanage, W., Matus, M., Ghaeli, N., Endo, N., Duvallet, C., Poyet, M., Moniz, K., Washburne, A.D., Erickson, T.B., Chai, P.R., Thompson, J., Alma, E.J.
Other Authors:	NUS ENVIRONMENTAL RESEARCH INSTITUTE
Format:	Article
Published:	American Society for Microbiology 2021
Subjects:	COVID-19 prevalence PMMoV SARS-CoV-2 Viral titers Wastewater
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/197903
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Longitudinal wastewater-based surveillance for SARS-CoV-2 in high-density student dormitories in Singapore
by: Ng, Wei Jie, et al.
Published: (2024)

Making waves: wastewater surveillance of SARS-CoV-2 in an endemic future
by: Wu, Fuqing, et al.
Published: (2022)

Making waves : wastewater surveillance of SARS-CoV-2 for population-based health management
by: Thompson, Janelle R., et al.
Published: (2021)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

The novel SARS-CoV-2 pandemic: Possible environmental transmission, detection, persistence and fate during wastewater and water treatment
by: Mohapatra, S, et al.
Published: (2022)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2022)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

Modelling lockdown and exit strategies for COVID-19 in Singapore
by: DICKENS, BORAME SUE LEE, et al.
Published: (2021)

Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
by: Ng, Oi Wing, et al.
Published: (2016)

Development of an efficient wastewater testing protocol for high-throughput country-wide SARS-CoV-2 monitoring
by: Mailepessov, D, et al.
Published: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

Wastewater surveillance of SARS-CoV-2 and chemical markers in campus dormitories in an evolving COVID − 19 pandemic
by: Mohapatra, S, et al.
Published: (2023)

Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV
by: Manopo, I., et al.
Published: (2012)

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023)

COVID-19 Science Report: Vaccines
by: Jason Chin-Huat YAP, et al.
Published: (2020)

The spike and 3A proteins of severe acute respiratory syndrome coronavirus (SARS-CoV): Expressions and interactions in mammalian cells
by: SOONG POH LOONG
Published: (2010)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
by: Zhang, Haiping, et al.
Published: (2021)

Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility
by: Cheng, Hui Mei, et al.
Published: (2021)

Screening, expression, and identification of nanobody against SARS-CoV-2 spike protein
by: Su, Qianling, et al.
Published: (2023)

Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Aw, Zhen Qin, et al.
Published: (2023)

EVALUATION OF ADAPTIVE IMMUNITY INDUCED BY VACCINATION AND INFECTION
by: NICHOLAS KHOO KIM HUAT
Published: (2023)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

Disease prevalence matters: Challenge for SARS-CoV-2 testing
by: Lau, Chin-Shern, et al.
Published: (2022)

Laboratory practice in the face of Covid-19
by: Lau, C.S., et al.
Published: (2021)

Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients
by: Kong, S.L., et al.
Published: (2012)

Positive anti-SSA/Ro antibody in a woman with SARS-CoV-2 infection using immunophenotyping: A case report
by: Huang, P.-I., et al.
Published: (2021)

Metrics to relate COVID-19 wastewater data to clinical testing dynamics
by: Xiao, Amy, et al.
Published: (2022)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit
by: Wu, Yanjun, et al.
Published: (2024)

COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection
by: Mahyuddin, Aniza P., et al.
Published: (2024)

Expression, post-translational modification and biochemical characterization of proteins encoded by subgenomic mRNA8 of the severe acute respiratory syndrome coronavirus
by: Le, T.M., et al.
Published: (2014)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug
by: Gan, Hanjie Jonathan, et al.
Published: (2022)

NMR structure and localization of a large fragment of the SARS-CoV fusion protein : implications in viral cell fusion
by: Pillay, Shubhadra, et al.
Published: (2019)

Structural basis and function of the N terminus of SARS-CoV-2 nonstructural protein 1
by: Zhao, Kaitao, et al.
Published: (2022)

Environmental contamination of SARS-CoV-2 in a non-healthcare setting
by: Wong, Judith Chui Ching, et al.
Published: (2021)